Nilotinib Trial Recruitment Underway

Nilotinib Trial Recruitment Underway
We are pleased that recruitment is now underway on an ongoing basis at 25 clinical sites across the United States of the phase 11a trial to assess the safety and tolerability of Nilotinib in Parkinson's.  The Michael J Fox Foundation (MJFF) has collaborated with Van Andel Research Institute(VARI) and The Cure Parkinson's Trust(CPT) toward the development and launch of this clinical ... read more
Source: The Cure Parkinson’s TrustPublished on 2019-01-16